Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function

Transplantation Proceedings(2017)10.1016/j.transproceed.2016.11.018Source: DataRank Database

Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function is a research paper published in Transplantation Proceedings (2017). On theSindex it has a DataRank of 0.411. It has been cited 5 times, with 5 citing works in its 1-hop citation network.

N/A

0.411DataRank · unranked

Scored on demand from live citation data

5 citations · 5 citing works in its network

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.51)OA: closedTopics (56)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 65%Citation Network 35%

Base Score Contribution

0.269

From this paper's citation signal

Citation Network Contribution

0.142

From 4 citing papers with measurable signal

Learn more about DataRank methodology →

Authors (6)

Y. Yamada,Y. Higuchi,K. Shimatani,A. Kanematsu,S. Yamamoto ORCID

Live enrichment

PubMed:28104155 OpenAlex:https://openalex.org/W2571829990

FWCI

0.51

Citation Percentile

0.6%

Citation Trend

2017

2018

2021

closedLicense: https://www.elsevier.com/tdm/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0041134516308521?httpAccept=text/plain

publisherhttps://api.elsevier.com/content/article/PII:S0041134516308521?httpAccept=text/xml

journalhttps://doi.org/10.1016/j.transproceed.2016.11.018

repositoryhttps://pubmed.ncbi.nlm.nih.gov/28104155

Fields of Study

Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and OutcomesBiological Research and Disease StudiesAdultCalcineurin InhibitorsCyclosporineDrug Therapy, CombinationEverolimusFemaleGraft SurvivalHumansImmunosuppression TherapyImmunosuppressive AgentsKidneyKidney TransplantationMaleMiddle AgedTacrolimusTime FactorsTransplantsYoung Adult

MeSH Terms

EverolimusAdultDrug Therapy, CombinationFemaleGraft SurvivalHumansImmunosuppression TherapyImmunosuppressive AgentsKidneyMaleMiddle AgedTime FactorsKidney TransplantationTacrolimusCyclosporineTransplantsYoung AdultCalcineurin Inhibitors

Keywords

CalcineurinImmunosuppressionEverolimusUrologyNephrotoxicityMedicineRenal functionTacrolimusKidney transplantationTransplantationBelataceptNephrologyRegimenSurgeryKidneyInternal medicineKidney transplant

Sustainable Development Goals

SDG 0: No poverty